ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop Conference ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop Matt Zierhut, PhD MBA2026年7月9日
Dosimetry for radiopharmaceutical therapy: From measurement to dose justification Blog Dosimetry for radiopharmaceutical therapy: From measurement to dose justification Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…Hunter Stephens, PhD2026年7月7日
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors On-Demand Webinar The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…Certara2026年7月1日
Enhancing clinical trials with real-world evidence in pregnancy research Blog リアルワールドエビデンスを活用した妊娠研究における臨床試験の強化 Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…Alekhya Lavu, PhD, PharmD2026年6月26日
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development Announcement サターラ、Bio Venture Catalystを発表:バイオテクノロジー企業の投資リスク低減と開発加速を支援 Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…Danielle Pillsbury2026年6月23日
Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies Poster Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…Certara2026年6月23日
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Poster Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…Certara2026年6月23日
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Poster Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…Certara2026年6月22日
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices Poster Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…Certara2026年6月22日
Machine Learning based drug renal clearance predictor development and application Poster Machine Learning based drug renal clearance predictor development and application A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…Certara2026年6月22日